img

Global Isoprinosine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Isoprinosine Market Insights, Forecast to 2034

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Isoprinosine estimated at US$ 241.24 million in the year 2024, is projected to reach a revised size of US$ 301.7 million by 2029, growing at a CAGR of 3.8% during the forecast period 2024-2034.
The North America market for Isoprinosine is estimated to increase from $ 2.61 million in 2024 to reach $ 3.42 million by 2029, at a CAGR of 4.61% during the forecast period of 2024 through 2029.
The China market for Isoprinosine is estimated to increase from $ 4.65 million in 2024 to reach $ 6.07 million by 2029, at a CAGR of 4.54% during the forecast period of 2024 through 2029.
The Europe market for Isoprinosine is estimated to increase from $ 152.75 million in 2024 to reach $ 190.35 million by 2029, at a CAGR of 3.74% during the forecast period of 2024 through 2029.
The global key manufacturers of Isoprinosine include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex, and Sanfer, etc. In 2022, the global top five players had a share approximately 69% in terms of revenue.
Report Includes
This report presents an overview of global market for Isoprinosine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2029.
This report researches the key producers of Isoprinosine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Isoprinosine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Chile, China, Japan, South Korea, Southeast Asia, India, Italy, the France, Hungary, Middle East, Africa, and Other Countries.
This report focuses on the Isoprinosine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Isoprinosine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Isoprinosine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex, and Sanfer, etc.




By Company


 Newport Pharmaceuticals
 Gedeon Richter
 Mochida
 Sanofi
 Andrómaco
 Yung Shin
 Alfasigma SpA
 Polfarmex
 Sanfer
 Meprofarm
 Novell Pharmaceutical
 Aflofarm
 KoRa Healthcare

Segment by Type
 Tablet
 Syrup


Segment by Application


 Hospital & Clinic
 Pharmacy
 Other


Segment by Region


North America
 U.S.
 Canada
China
Asia (excluding China)
 Japan
 South Korea
 Southeast Asia
 India
Europe
 Italy
 Poland
 France
 Hungary
 Russia
Middle East, Africa, Latin America
 Chile
 Mexico
 Middle East
 Africa




Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Isoprinosine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Isoprinosine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (North America) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8China by Type, and by Application, sales, and revenue for each segment.
Chapter 9Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isoprinosine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 STUDY COVERAGE 1
1.1 Isoprinosine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Isoprinosine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 2
1.2.2 Tablet 3
1.2.3 Syrup 4
1.3 Market by Application 5
1.3.1 Global Isoprinosine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 5
1.3.2 Hospital & Clinic 6
1.3.3 Pharmacy 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 9
2 EXECUTIVE SUMMARY 11
2.1 Global Isoprinosine Revenue Estimates and Forecasts 2018-2029 11
2.2 Global Isoprinosine Revenue by Region 12
2.2.1 Global Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 12
2.2.2 Global Isoprinosine Revenue by Region (2018-2024) 15
2.2.3 Global Isoprinosine Revenue by Region (2024-2029) 15
2.2.4 Global Isoprinosine Revenue Market Share by Region (2018-2029) 15
2.3 Global Isoprinosine Sales Estimates and Forecasts 2018-2029 17
2.4 Global Isoprinosine Sales by Region 17
2.4.1 Global Isoprinosine Sales by Region: 2018 VS 2022 VS 2029 17
2.4.2 Global Isoprinosine Sales by Region (2018-2024) 18
2.4.3 Global Sales Isoprinosine by Region (2024-2029) 18
2.4.4 Global Isoprinosine Sales Market Share by Region (2018-2029) 19
2.5 North America 20
2.6 Europe 21
2.7 China 22
2.8 Asia (excluding China) 23
2.9 Middle East, Africa and Latin America 24
3 COMPETITION BY MANUFACTURERS 26
3.1 Global Isoprinosine Sales by Manufacturers 26
3.1.1 Global Isoprinosine Sales by Manufacturers (2018-2024) 26
3.1.2 Global Isoprinosine Sales Market Share by Manufacturers (2018-2024) 27
3.1.3 Global Top Largest Manufacturers of Isoprinosine in 2022 27
3.2 Global Isoprinosine Revenue by Manufacturers 28
3.2.1 Global Isoprinosine Revenue by Manufacturers (2018-2024) 28
3.2.2 Global Isoprinosine Revenue Market Share by Manufacturers (2018-2024) 29
3.2.3 Global Top Companies by Isoprinosine Revenue in 2022 30
3.3 Global Key Players of Isoprinosine, Industry Ranking, 2021 VS 2022 30
3.4 Global Isoprinosine Sales Price by Manufacturers (2018-2024) 31
3.5 Analysis of Competitive Landscape 32
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 32
3.5.2 Global Isoprinosine Market by Company Type (Tier 1, Tier 2, and Tier 3) 32
3.6 Global Key Manufacturers of Isoprinosine, Manufacturing Base Distribution and Headquarters 33
3.7 Global Key Manufacturers of Isoprinosine, Product Offered 34
3.8 Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry 34
3.9 ***Mergers & Acquisitions, Expansion Plans 35
4 MARKET SIZE BY TYPE 36
4.1 Global Isoprinosine Sales by Type 36
4.1.1 Global Isoprinosine Historical Sales by Type (2018-2024) 36
4.1.2 Global Isoprinosine Forecasted Sales by Type (2024-2029) 36
4.1.3 Global Isoprinosine Sales Market Share by Type (2018-2029) 36
4.2 Global Isoprinosine Revenue by Type 37
4.2.1 Global Isoprinosine Historical Revenue by Type (2018-2024) 37
4.2.2 Global Isoprinosine Forecasted Revenue by Type (2024-2029) 38
4.2.3 Global Isoprinosine Revenue Market Share by Type (2018-2029) 38
4.3 Global Isoprinosine Price by Type 39
4.3.1 Global Isoprinosine Price by Type (2018-2024) 39
4.3.2 Global Isoprinosine Price Forecast by Type (2024-2029) 39
5 MARKET SIZE BY APPLICATION 40
5.1 Global Isoprinosine Sales by Application 40
5.1.1 Global Isoprinosine Historical Sales by Application (2018-2024) 40
5.1.2 Global Isoprinosine Forecasted Sales by Application (2024-2029) 40
5.1.3 Global Isoprinosine Sales Market Share by Application (2018-2029) 40
5.2 Global Isoprinosine Revenue by Application 41
5.2.1 Global Isoprinosine Historical Revenue by Application (2018-2024) 41
5.2.2 Global Isoprinosine Forecasted Revenue by Application (2024-2029) 42
5.2.3 Global Isoprinosine Revenue Market Share by Application (2018-2029) 42
5.3 Global Isoprinosine Price by Application 43
5.3.1 Global Isoprinosine Price by Application (2018-2024) 43
5.3.2 Global Isoprinosine Price Forecast by Application (2024-2029) 43
6 NORTH AMERICA 44
6.1 North America Isoprinosine Market Size by Type 44
6.1.1 North America Isoprinosine Sales by Type (2018-2029) 44
6.1.2 North America Isoprinosine Revenue by Type (2018-2029) 44
6.2 North America Isoprinosine Market Size by Application 45
6.2.1 North America Isoprinosine Sales by Application (2018-2029) 45
6.2.2 North America Isoprinosine Revenue by Application (2018-2029) 46
6.3 North America Isoprinosine Market Size by Country 47
6.3.1 North America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 47
6.3.2 North America Isoprinosine Revenue by Country (2018-2029) 47
6.3.3 North America Isoprinosine Sales by Country (2018-2029) 47
6.3.4 Canada 48
7 EUROPE 49
7.1 Europe Isoprinosine Market Size by Type 49
7.1.1 Europe Isoprinosine Sales by Type (2018-2029) 49
7.1.2 Europe Isoprinosine Revenue by Type (2018-2029) 50
7.2 Europe Isoprinosine Market Size by Application 51
7.2.1 Europe Isoprinosine Sales by Application (2018-2029) 51
7.2.2 Europe Isoprinosine Revenue by Application (2018-2029) 52
7.3 Europe Isoprinosine Market Size by Country 53
7.3.1 Europe Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 53
7.3.2 Europe Isoprinosine Revenue by Country (2018-2029) 53
7.3.3 Europe Isoprinosine Sales by Country (2018-2029) 54
7.3.4 Italy 56
7.3.5 Poland 56
7.3.6 France 57
7.3.7 Hungary 57
7.3.8 Russia 58
8 CHINA 59
8.1 China Isoprinosine Market Size by Type 59
8.1.1 China Isoprinosine Sales by Type (2018-2029) 59
8.1.2 China Isoprinosine Revenue by Type (2018-2029) 60
8.2 China Isoprinosine Market Size by Application 61
8.2.1 China Isoprinosine Sales by Application (2018-2029) 61
8.2.2 China Isoprinosine Revenue by Application (2018-2029) 62
9 ASIA (EXCLUDING CHINA) 63
9.1 Asia Isoprinosine Market Size by Type 63
9.1.1 Asia Isoprinosine Sales by Type (2018-2029) 63
9.1.2 Asia Isoprinosine Revenue by Type (2018-2029) 64
9.2 Asia Isoprinosine Market Size by Application 65
9.2.1 Asia Isoprinosine Sales by Application (2018-2029) 65
9.2.2 Asia Isoprinosine Revenue by Application (2018-2029) 66
9.3 Asia Isoprinosine Market Size by Region 67
9.3.1 Asia Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 67
9.3.2 Asia Isoprinosine Revenue by Region (2018-2029) 67
9.3.3 Asia Isoprinosine Sales by Region (2018-2029) 68
9.3.4 Japan 69
9.3.5 South Korea 70
9.3.6 Southeast Asia 70
9.3.7 India 71
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 72
10.1 Middle East, Africa and Latin America Isoprinosine Market Size by Type 72
10.1.1 Middle East, Africa and Latin America Isoprinosine Sales by Type (2018-2029) 72
10.1.2 Middle East, Africa and Latin America Isoprinosine Revenue by Type (2018-2029) 73
10.2 Middle East, Africa and Latin America Isoprinosine Market Size by Application 74
10.2.1 Middle East, Africa and Latin America Isoprinosine Sales by Application (2018-2029) 74
10.2.2 Middle East, Africa and Latin America Isoprinosine Revenue by Application (2018-2029) 75
10.3 Middle East, Africa and Latin America Isoprinosine Market Size by Country 77
10.3.1 Middle East, Africa and Latin America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 77
10.3.2 Middle East, Africa and Latin America Isoprinosine Revenue by Country (2018-2029) 77
10.3.3 Middle East, Africa and Latin America Isoprinosine Sales by Country (2018-2029) 78
10.3.4 Chile 80
10.3.5 Mexico 80
10.3.6 Middle East 81
10.3.7 Africa 81
11 CORPORATE PROFILE 82
11.1 Newport Pharmaceuticals 82
11.1.1 Newport Pharmaceuticals Company Information 82
11.1.2 Newport Pharmaceuticals Overview 82
11.1.3 Newport Pharmaceuticals Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 83
11.1.4 Newport Pharmaceuticals Isoprinosine Product Introduction 83
11.1.5 Newport Pharmaceuticals Recent Developments 84
11.2 Gedeon Richter 85
11.2.1 Gedeon Richter Company Information 85
11.2.2 Gedeon Richter Overview 85
11.2.3 Gedeon Richter Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 86
11.2.4 Gedeon Richter Isoprinosine Product Introduction 86
11.2.5 Gedeon Richter Recent Developments 87
11.3 Mochida 88
11.3.1 Mochida Company Information 88
11.3.2 Mochida Overview 89
11.3.3 Mochida Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 90
11.3.4 Mochida Isoprinosine Product Introduction 90
11.4 Sanofi 91
11.4.1 Sanofi Company Information 91
11.4.2 Sanofi Overview 91
11.4.3 Sanofi Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 92
11.4.4 Sanofi Isoprinosine Product Introduction 92
11.4.5 Sanofi Recent Developments 92
11.5 Andrómaco 93
11.5.1 Andrómaco Company Information 93
11.5.2 Andrómaco Overview 93
11.5.3 Andrómaco Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 94
11.5.4 Andrómaco Isoprinosine Product Introduction 94
11.6 Yung Shin 95
11.6.1 Yung Shin Company Information 95
11.6.2 Yung Shin Overview 95
11.6.3 Yung Shin Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 96
11.6.4 Yung Shin Isoprinosine Product Introduction 96
11.7 Alfasigma S.p.A. 97
11.7.1 Alfasigma S.p.A. Company Information 97
11.7.2 Alfasigma S.p.A. Overview 97
11.7.3 Alfasigma S.p.A. Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 98
11.7.4 Alfasigma S.p.A. Isoprinosine Product Introduction 98
11.8 Polfarmex 99
11.8.1 Polfarmex Company Information 99
11.8.2 Polfarmex Overview 100
11.8.3 Polfarmex Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 100
11.8.4 Polfarmex Isoprinosine Product Introduction 101
11.9 Sanfer 102
11.9.1 Sanfer Company Information 102
11.9.2 Sanfer Overview 103
11.9.3 Sanfer Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 104
11.9.4 Sanfer Isoprinosine Product Introduction 104
11.10 Meprofarm 105
11.10.1 Meprofarm Company Information 105
11.10.2 Meprofarm Overview 106
11.10.3 Meprofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 106
11.10.4 Meprofarm Isoprinosine Product Introduction 106
11.11 Novell Pharmaceutical 107
11.11.1 Novell Pharmaceutical Company Information 107
11.11.2 Novell Pharmaceutical Overview 108
11.11.3 Novell Pharmaceutical Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 109
11.11.4 Novell Pharmaceutical Isoprinosine Product Introduction 109
11.12 Aflofarm 109
11.12.1 Aflofarm Company Information 109
11.12.2 Aflofarm Overview 110
11.12.3 Aflofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 110
11.12.4 Aflofarm Isoprinosine Product Introduction 111
11.13 KoRa Healthcare 112
11.13.1 KoRa Healthcare Company Information 112
11.13.2 KoRa Healthcare Overview 113
11.13.3 KoRa Healthcare Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2024) 114
11.13.4 KoRa Healthcare Isoprinosine Product Introduction 114
11.13.5 KoRa Healthcare Recent Developments 115
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 116
12.1 Isoprinosine Industry Chain Analysis 116
12.2 Isoprinosine Key Raw Materials 117
12.2.1 Key Raw Materials 117
12.2.2 Raw Materials Key Suppliers 117
12.3 Isoprinosine Production Mode & Process 119
12.4 Isoprinosine Sales and Marketing 120
12.4.1 Isoprinosine Sales Channels 120
12.4.2 Isoprinosine Distributors 121
12.5 Isoprinosine Customers 123
13 ISOPRINOSINE MARKET DYNAMICS 125
13.1.1 Isoprinosine Industry Trends 125
13.1.2 Isoprinosine Market Drivers 126
13.1.3 Isoprinosine Market Challenges 127
13.1.4 Isoprinosine Market Restraints 128
14 KEY FINDINGS IN THE GLOBAL ISOPRINOSINE STUDY 129
15 APPENDIX 131
15.1 Research Methodology 131
15.1.1 Methodology/Research Approach 131
15.1.2 Data Source 134
15.2 Author Details 137
15.3 Disclaimer 139

List of Figure

Table 1. Global Isoprinosine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) 2
Table 2. Global Isoprinosine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) 5
Table 3. Global Isoprinosine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 13
Table 4. Global Isoprinosine Revenue by Region (2018-2024) & (US$ Million) 15
Table 5. Global Isoprinosine Revenue by Region (2024-2029) & (US$ Million) 15
Table 6. Global Isoprinosine Revenue Market Share by Region (2018-2024) 15
Table 7. Global Isoprinosine Revenue Market Share by Region (2024-2029) 16
Table 8. Global Isoprinosine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (K Units) 17
Table 9. Global Isoprinosine Sales by Region (2018-2024) & (K Units) 18
Table 10. Global Isoprinosine Sales by Region (2024-2029) & (K Units) 18
Table 11. Global Isoprinosine Sales Market Share by Region (2018-2024) 19
Table 12. Global Isoprinosine Sales Market Share by Region (2024-2029) 19
Table 13. Global Isoprinosine Sales by Manufacturers (2018-2024) & (K Units) 26
Table 14. Global Isoprinosine Sales Share by Manufacturers (2018-2024) 27
Table 15. Global Isoprinosine Revenue by Manufacturers (2018-2024) & (US$ Million) 28
Table 16. Global Isoprinosine Revenue Market Share by Manufacturers (2018-2024) 29
Table 17. Global Key Players of Isoprinosine, Industry Ranking, 2021 VS 2022 30
Table 18. Isoprinosine Price by Manufacturers (2018-2024) & (USD/Unit) 31
Table 19. Global Isoprinosine Manufacturers Market Concentration Ratio (CR5 and HHI) 32
Table 20. Global Isoprinosine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoprinosine as of 2022) 33
Table 21. Global Key Manufacturers of Isoprinosine, Manufacturing Base Distribution and Headquarters 33
Table 22. Global Key Manufacturers of Isoprinosine, Product Offered 34
Table 23. Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry 34
Table 24. Mergers & Acquisitions, Expansion Plans 35
Table 25. Global Isoprinosine Sales by Type (2018-2024) & (K Units) 36
Table 26. Global Isoprinosine Sales by Type (2024-2029) & (K Units) 36
Table 27. Global Isoprinosine Sales Share by Type (2018-2024) 36
Table 28. Global Isoprinosine Sales Share by Type (2024-2029) 37
Table 29. Global Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 37
Table 30. Global Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 38
Table 31. Global Isoprinosine Revenue Share by Type (2018-2024) 38
Table 32. Global Isoprinosine Revenue Share by Type (2024-2029) 38
Table 33. Isoprinosine Price by Type (2018-2024) & (USD/Unit) 39
Table 34. Global Isoprinosine Price Forecast by Type (2024-2029) & (USD/Unit) 39
Table 35. Global Isoprinosine Sales by Application (2018-2024) & (K Units) 40
Table 36. Global Isoprinosine Sales by Application (2024-2029) & (K Units) 40
Table 37. Global Isoprinosine Sales Share by Application (2018-2024) 40
Table 38. Global Isoprinosine Sales Share by Application (2024-2029) 41
Table 39. Global Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 41
Table 40. Global Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 42
Table 41. Global Isoprinosine Revenue Share by Application (2018-2024) 42
Table 42. Global Isoprinosine Revenue Share by Application (2024-2029) 42
Table 43. Isoprinosine Price by Application (2018-2024) & (USD/Unit) 43
Table 44. Global Isoprinosine Price Forecast by Application (2024-2029) & (USD/Unit) 43
Table 45. North America Isoprinosine Sales by Type (2018-2024) & (K Units) 44
Table 46. North America Isoprinosine Sales by Type (2024-2029) & (K Units) 44
Table 47. North America Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 44
Table 48. North America Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 44
Table 49. North America Isoprinosine Sales by Application (2018-2024) & (K Units) 45
Table 50. North America Isoprinosine Sales by Application (2024-2029) & (K Units) 45
Table 51. North America Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 46
Table 52. North America Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 46
Table 53. North America Isoprinosine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 47
Table 54. North America Isoprinosine Revenue by Country (2018-2024) & (US$ Million) 47
Table 55. North America Isoprinosine Revenue by Country (2024-2029) & (US$ Million) 47
Table 56. North America Isoprinosine Sales by Country (2018-2024) & (K Units) 47
Table 57. North America Isoprinosine Sales by Country (2024-2029) & (K Units) 48
Table 58. Europe Isoprinosine Sales by Type (2018-2024) & (K Units) 49
Table 59. Europe Isoprinosine Sales by Type (2024-2029) & (K Units) 49
Table 60. Europe Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 50
Table 61. Europe Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 50
Table 62. Europe Isoprinosine Sales by Application (2018-2024) & (K Units) 51
Table 63. Europe Isoprinosine Sales by Application (2024-2029) & (K Units) 51
Table 64. Europe Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 52
Table 65. Europe Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 52
Table 66. Europe Isoprinosine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 53
Table 67. Europe Isoprinosine Revenue by Country (2018-2024) & (US$ Million) 53
Table 68. Europe Isoprinosine Revenue by Country (2024-2029) & (US$ Million) 53
Table 69. Europe Isoprinosine Sales by Country (2018-2024) & (K Units) 54
Table 70. Europe Isoprinosine Sales by Country (2024-2029) & (K Units) 54
Table 71. China Isoprinosine Sales by Type (2018-2024) & (K Units) 59
Table 72. China Isoprinosine Sales by Type (2024-2029) & (K Units) 59
Table 73. China Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 60
Table 74. China Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 60
Table 75. China Isoprinosine Sales by Application (2018-2024) & (K Units) 61
Table 76. China Isoprinosine Sales by Application (2024-2029) & (K Units) 61
Table 77. China Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 62
Table 78. China Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 62
Table 79. Asia Isoprinosine Sales by Type (2018-2024) & (K Units) 63
Table 80. Asia Isoprinosine Sales by Type (2024-2029) & (K Units) 63
Table 81. Asia Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 64
Table 82. Asia Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 64
Table 83. Asia Isoprinosine Sales by Application (2018-2024) & (K Units) 65
Table 84. Asia Isoprinosine Sales by Application (2024-2029) & (K Units) 65
Table 85. Asia Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 66
Table 86. Asia Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 66
Table 87. Asia Isoprinosine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 67
Table 88. Asia Isoprinosine Revenue by Region (2018-2024) & (US$ Million) 67
Table 89. Asia Isoprinosine Revenue by Region (2024-2029) & (US$ Million) 67
Table 90. Asia Isoprinosine Sales by Region (2018-2024) & (K Units) 68
Table 91. Asia Isoprinosine Sales by Region (2024-2029) & (K Units) 68
Table 92. Middle East, Africa and Latin America Isoprinosine Sales by Type (2018-2024) & (K Units) 72
Table 93. Middle East, Africa and Latin America Isoprinosine Sales by Type (2024-2029) & (K Units) 72
Table 94. Middle East, Africa and Latin America Isoprinosine Revenue by Type (2018-2024) & (US$ Million) 73
Table 95. Middle East, Africa and Latin America Isoprinosine Revenue by Type (2024-2029) & (US$ Million) 73
Table 96. Middle East, Africa and Latin America Isoprinosine Sales by Application (2018-2024) & (K Units) 74
Table 97. Middle East, Africa and Latin America Isoprinosine Sales by Application (2024-2029) & (K Units) 75
Table 98. Middle East, Africa and Latin America Isoprinosine Revenue by Application (2018-2024) & (US$ Million) 75
Table 99. Middle East, Africa and Latin America Isoprinosine Revenue by Application (2024-2029) & (US$ Million) 76
Table 100. Middle East, Africa and Latin America Isoprinosine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 77
Table 101. Middle East, Africa and Latin America Isoprinosine Revenue by Country (2018-2024) & (US$ Million) 77
Table 102. Middle East, Africa and Latin America Isoprinosine Revenue by Country (2024-2029) & (US$ Million) 78
Table 103. Middle East, Africa and Latin America Isoprinosine Sales by Country (2018-2024) & (K Units) 78
Table 104. Middle East, Africa and Latin America Isoprinosine Sales by Country (2024-2029) & (K Units) 79
Table 105. Newport Pharmaceuticals Company Information 82
Table 106. Newport Pharmaceuticals Description and Major Businesses 82
Table 107. Newport Pharmaceuticals Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 83
Table 108. Newport Pharmaceuticals Isoprinosine Product Introduction 83
Table 109. Newport Pharmaceuticals Recent Developments 84
Table 110. Gedeon Richter Company Information 85
Table 111. Gedeon Richter Description and Major Businesses 85
Table 112. Gedeon Richter Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 86
Table 113. Gedeon Richter Isoprinosine Product Introduction 86
Table 114. Gedeon Richter Recent Developments 87
Table 115. Mochida Company Information 88
Table 116. Mochida Description and Major Businesses 89
Table 117. Mochida Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 90
Table 118. Mochida Isoprinosine Product Introduction 90
Table 119. Sanofi Company Information 91
Table 120. Sanofi Description and Major Businesses 91
Table 121. Sanofi Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 92
Table 122. Sanofi Isoprinosine Product Introduction 92
Table 123. Sanofi Recent Developments 92
Table 124. Andrómaco Company Information 93
Table 125. Andrómaco Description and Major Businesses 93
Table 126. Andrómaco Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 94
Table 127. Andrómaco Isoprinosine Product Introduction 94
Table 128. Yung Shin Company Information 95
Table 129. Yung Shin Description and Major Businesses 95
Table 130. Yung Shin Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 96
Table 131. Yung Shin Isoprinosine Product Introduction 96
Table 132. Alfasigma S.p.A. Company Information 97
Table 133. Alfasigma S.p.A. Description and Major Businesses 97
Table 134. Alfasigma S.p.A. Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 98
Table 135. Alfasigma S.p.A. Isoprinosine Product Introduction 98
Table 136. Polfarmex Company Information 99
Table 137. Polfarmex Description and Major Businesses 100
Table 138. Polfarmex Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 100
Table 139. Polfarmex Isoprinosine Product Introduction 101
Table 140. Sanfer Company Information 102
Table 141. Sanfer Description and Major Businesses 103
Table 142. Sanfer Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 104
Table 143. Sanfer Isoprinosine Product Introduction 104
Table 144. Meprofarm Company Information 105
Table 145. Meprofarm Description and Major Businesses 106
Table 146. Meprofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 106
Table 147. Meprofarm Isoprinosine Product Introduction 106
Table 148. Novell Pharmaceutical Company Information 107
Table 149. Novell Pharmaceutical Description and Major Businesses 108
Table 150. Novell Pharmaceutical Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 109
Table 151. Novell Pharmaceutical Isoprinosine Product Introduction 109
Table 152. Aflofarm Company Information 109
Table 153. Aflofarm Description and Major Businesses 110
Table 154. Aflofarm Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 110
Table 155. Aflofarm Isoprinosine Product Introduction 111
Table 156. KoRa Healthcare Company Information 112
Table 157. KoRa Healthcare Description and Major Businesses 113
Table 158. KoRa Healthcare Isoprinosine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024) 114
Table 159. KoRa Healthcare Isoprinosine Product Introduction 114
Table 160. KoRa Healthcare Recent Developments 115
Table 161. Key Raw Materials Lists 117
Table 162. Raw Materials Key Suppliers Lists 117
Table 163. Isoprinosine Distributors List 121
Table 164. Isoprinosine Customers List 123
Table 165. Isoprinosine Market Trends 125
Table 166. Isoprinosine Market Drivers 126
Table 167. Isoprinosine Market Challenges 127
Table 168. Isoprinosine Market Restraints 128
Table 169. Research Programs/Design for This Report 131
Table 170. Key Data Information from Secondary Sources 134
Table 171. Key Data Information from Primary Sources 135
Table 172. QYR Business Unit and Senior & Team Lead Analysts 137

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries